Actinium Pharmaceuticals (Delaware) (ATNM)'s 30-day implied volatility (IV30) was 90.3% at the close on November 13, 2026, down from 92.2% the day before, against a 52-week range of 42.7% to 260.0%. Its 20-day historical volatility was 104.1%.
Data as of November 13, 2026.